Mirissa Hewage Dumindu Kavinda

Mr. Mirissa Hewage Dumindu Kavinda

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
Neelaka MolagodaNeelaka Molagoda
Neelaka Molagoda
MKMirissa Hewage Dumindu Kavinda
Mirissa Hewage Dumindu Kavinda
Yung Hyun ChoiYung Hyun Choi
Yung Hyun Choi
HLHyesook Lee
Hyesook Lee
CKChang-Hee Kang
Chang-Hee Kang
Gi-Young KimGi-Young Kim
Gi-Young Kim
Fine particulate matter (PM2.5) originates from the combustion of coal and is found in the exhaust of fumes of diesel vehicles. PM2.5 readily penetrates the skin via the aryl hydrocarbon receptor, causing skin senescence, inflammatory skin diseases, DNA damage, and carcinogenesis. In this study, we investigated whether fisetin, a bioactive flavonoid, prevents PM2.5-induced apoptosis in HaCaT human keratinocytes. The results demonstrated that fisetin significantly downregulated PM2.5-induced apoptosis at concentrations below 10 μM. Fisetin strongly inhibited the production of reactive oxygen species (ROS) and the expression of pro-apoptotic proteins. The PM2.5-induced apoptosis was associated with the induction of the endoplasmic reticulum (ER) stress response, mediated via the protein kinase R-like ER kinase (PERK)–eukaryotic initiation factor 2α (eIF2α)–activating transcription factor 4 (ATF4)–CCAAT-enhancer-binding protein (C/EBP) homologous protein (CHOP) axis. Additionally, the cytosolic Ca2+ levels were markedly increased following exposure to PM2.5. However, fisetin inhibited the expression of ER stress-related proteins, including 78 kDa glucose-regulated protein (GRP78), phospho-eIF2α, ATF4, and CHOP, and reduced the cytosolic Ca2+ levels. These data suggest that fisetin inhibits PM2.5-induced apoptosis by inhibiting the ER stress response and production of ROS.

Verified
Journal Article
Open access
PDF file
Neelaka MolagodaNeelaka Molagoda
Neelaka Molagoda
MKMirissa Hewage Dumindu Kavinda
Mirissa Hewage Dumindu Kavinda
HRHyung Won Ryu
Hyung Won Ryu
Yung Hyun ChoiYung Hyun Choi
Yung Hyun Choi
Jin-Woo JeongJin-Woo Jeong
Jin-Woo Jeong
Gi-Young KimGi-Young Kim
Gi-Young Kim
Gamma-aminobutyric acid (GABA) is considered the primary inhibitory neurotransmitter in the human cortex. However, whether GABA regulates melanogenesis has not been comprehensively elucidated. In this study, we reveal that GABA (20 mM) significantly inhibited α-melanocyte-stimulating hormone (α-MSH)-induced extracellular (from 354.9% ± 28.4% to 126.5% ± 16.0%) and intracellular melanin contents (from 236.7% ± 11.1% to 102.7% ± 23.1%) in B16F10 melanoma cells, without inducing cytotoxicity. In addition, α-MSH-induced hyperpigmentation in zebrafish larvae was inhibited from 246.3% ± 5.4% to 116.3% ± 3.1% at 40 mM GABA, displaying no apparent cardiotoxicity. We also clarify that the GABA-mediated antimelanogenic properties were related to the direct inhibition of microphthalmia-associated transcription factor (MITF) and tyrosinase expression by inhibiting cyclic adenosine monophosphate (cAMP) and cAMP response element-binding protein (CREB). Furthermore, under α-MSH stimulation, GABA-related antimelanogenic effects were mediated through the GABAA and GABAB receptors, with subsequent inhibition of Ca2+ accumulation. In B16F10 melanoma cells and zebrafish larvae, pretreatment with bicuculline, a GABAA receptor antagonist, and CGP 46381, a GABAB receptor antagonist, reversed the antimelanogenic effect of GABA following α-MSH treatment by upregulating Ca2+ accumulation. In conclusion, our results indicate that GABA inhibits α-MSH-induced melanogenesis. Hence, in addition to the health benefits of GABA in the central nervous system, it could ameliorate hyperpigmentation disorders.

19 January 2024 in ACS Pharmacology & Translational Science
Verified
Journal Article
Closed access
MKMirissa Hewage Dumindu Kavinda
Mirissa Hewage Dumindu Kavinda
MLMi-Hwa Lee
Mi-Hwa Lee
CKChang-Hee Kang
Chang-Hee Kang
YCYung Hyun Choi
Yung Hyun Choi
Gi-Young KimGi-Young Kim
Gi-Young Kim

11 December 2025 in Phytomedicine
Verified
Journal Article
Closed access
MKMirissa Hewage Dumindu Kavinda
Mirissa Hewage Dumindu Kavinda
WKWisurumuni Arachchilage Hasitha Maduranga Karunarathne
Wisurumuni Arachchilage Hasitha Maduranga Karunarathne
KLKyoung Tae Lee
Kyoung Tae Lee
HKHyun-Min Kim
Hyun-Min Kim
YYYuji Yang
Yuji Yang
Gi-Young KimGi-Young Kim
Gi-Young Kim

27 April 2024 in ACS Pharmacology & Translational Science
Verified
Journal Article
Closed access
MKMirissa Hewage Dumindu Kavinda
Mirissa Hewage Dumindu Kavinda
YCYung Hyun Choi
Yung Hyun Choi
CKChang-Hee Kang
Chang-Hee Kang
MLMi-Hwa Lee
Mi-Hwa Lee
Gi-Young KimGi-Young Kim
Gi-Young Kim